TrialBest practice & research. Clinical haematology2011

Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide.

Ashley T Munchel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.